Compare Global X Cybersecurity (BUG) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Cybersecurity vs Neurocrine Biosciences Inc — how do they compare? Global X Cybersecurity trades at $42.48, while Neurocrine Biosciences Inc trades at $170.05 (market cap $17.51B). The key difference: Global X Cybersecurity is trading nearer its 52-week high, Neurocrine Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| BUG | NBIX | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $41.99 | $180.55 |
52-Week Low | $23.30 | $123.10 |
Market Cap | — | $17.51B |
Enterprise Value | — | $16.60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X Cybersecurity
BUG is a thematic ETF that invests in companies at the forefront of the global cybersecurity industry. It provides concentrated exposure to leaders in network security, endpoint protection, and cloud security, such as Fortinet, Akamai, and CrowdStrike.
Read more on BUG →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
